Intestinal Colonization With Carbapenem Resistant Enterobacteriaceae Among ICU Patients at Assiut University Hospital
November 20, 2025 updated by: Israa Ahmed abdelhalim
significant benefits by providing data to improve infection control, guide early detection, and reduce CRE transmission in ICUs.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
120
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
All eligible adult patients admitted during the study period
Description
Inclusion Criteria:
Adults (≥18 years)_
- Expected ICU stay ≥48 hours -
Exclusion Criteria:
- .ICU stay <48 hours
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Prospective cohort study conducted in the Adult ICU at Assiut University Hospital
|
Observational study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
rate of intestinal colonization with CRE
Time Frame: One year
|
One year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
February 1, 2026
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
June 5, 2027
Study Registration Dates
First Submitted
November 20, 2025
First Submitted That Met QC Criteria
November 20, 2025
First Posted (Actual)
December 1, 2025
Study Record Updates
Last Update Posted (Actual)
December 1, 2025
Last Update Submitted That Met QC Criteria
November 20, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Assiut_icu_catbapenem_2025
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.